期刊文献+

直接经皮腔内冠状动脉介入干预治疗急性心肌梗死的围手术期及中远期疗效评价

Evaluation of the efficacy of percutaneous transluminal coronary angioplasty and primary stent in acute myocardial infarction during perioperative period and follow-up
下载PDF
导出
摘要 目的 评价直接经皮腔内冠状动脉介入干预治疗急性心肌梗死 (AMI)的围手术期及中远期疗效。方法 1997年 1月至 1999年 4月行直接经皮腔内冠状动脉成形术 (PTCA)的急性心肌梗死患者 2 16例。比较这些病例在急性期及中远期的冠状动脉造影结果及临床疗效。结果 术后 2 0 3支梗死相关血管恢复TIMI 3级血流。住院及随访 18±2 4个月期间的死亡人数为 14人 (6 5 % ) ;住院期间非致命性再梗死 2人 ,再缺血发作 18 5 % ,12 %接受再次PTCA治疗 ,6%接受冠状动脉旁路移植术 (CABG)治疗。 79 6%的患者成功置入冠脉内支架 ,99%达TIMI 3级血流。随访中 ,2例死亡 ,3 2 %的患者出现非致命性再梗死 ,2 0 %的患者出现再缺血事件 ,5 %的患者再次接受PTCA治疗 ,6例患者接受CABG治疗。结论 直接PTCA及支架置入是治疗急性心肌梗死的安全有效的措施 ,成功率高 ,并发症少 ,术后复发心肌缺血发生率低。 Objectives Evaluate the efficacy of percutaneous transluminal coronary angioplasty(PTCA) and primary stent in acute myocardial infarction during perioperative period and follow-up. Methods Two hundred and sixteen AMI received direct PTCA within 12 hours from 1997-1999,203 of with restored flow TIMI 3.During 18±2.4 months follow-up,14(6.5%)died;2 had reinfarction,18.5% had reischemic attack,12% received repeated PTCA,6% received CABG operation.Amaong 79.6% successfull stented cases,99% achieved TIMI 3 flow.During follow-up,2 died,3.2% non-fatal reinfarction,20% experienced reishchemia,5% received repeated PTCA,6 cases received CABG therapy. Conclusions Direct angioplasty and primary stent was safe and reliable therapeutic maneuver in AMI with its high successful rate and low complication.
出处 《临床和实验医学杂志》 2002年第1期1-4,共4页 Journal of Clinical and Experimental Medicine
关键词 急性心肌梗死 直接PTCA 支架 Acute myocardial infarction Direct PTCA stent
  • 相关文献

参考文献10

  • 1Simes RJ,Topol EJ,Holmes DR Jr,et al.Link between the angiographic sub-study and mortality outcomes in a large randomized trial of myocardial reperfusion: Importance of early and complete infarct artery reperfusion[].Circulation.1995
  • 2Zijlstra H,de Boer MJ,Hoomtje JCA,et al.A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction[].The New England Journal of Medicine.1993
  • 3The RESTORE Investigators.The effect of platelet glycoprotein Ⅱb/Ⅲa blockade with tirofiban on adverse cardiac events in patients with unstabe angina or acute myocardial infartion undergoing coronary angioplasty[].Circulation.1997
  • 4Frishman WH,Burns B,Bulent A,et al.Novel antiplatelet therapeuties for treatment of patients with ischemic heart disease; inhibitors of the platelet glycoprotein Ⅱb/Ⅲa integrin receptor[].American Heart Journal.1995
  • 5Stome GW,Brodie BR. Brodie,et al.Prospective, multi - center study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of PAMI stent pilot trial[].Journal of the American College of Cardiology.1998
  • 6Weaver WD,Simes RJ,Betriu A,et al.Comparison of primary coronary angioplasty and intravenous thromblyotic therapy for acute myocardial infarction: a quantitative view[].The Journal of The American Medical Association.1997
  • 7The GUSTO Angiographic Investigators.The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after myocardial infarction[].The New England Journal of Medicine.1993
  • 8GUSTO-Ⅱb Angioplasty Substudy Investigators.A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction[].The New England Journal of Medicine.1997
  • 9Lamas GA,Flaker GC,Mitchell G,et al.Effects of infarc tartery patency on prognosis after acute myocardial infarction[].Circulation.1995
  • 10Boersma E,Maas CP,Deckers JW,et al.Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour[].The Lancet.1996

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部